![]() |
市場調查報告書
商品編碼
1967584
生物軟體動物殺蟲劑市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、應用、地區和競爭格局分類,2021-2031年Biological Molluscicides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F |
||||||
全球生物防治軟體動物害蟲市場預計將從 2025 年的 3.879 億美元成長到 2031 年的 5.1215 億美元,複合年成長率為 4.74%。
這些由細菌和植物萃取物等天然資源配製而成的害蟲防治劑,旨在控制蝸牛和蛞蝓的數量,同時最大限度地減少對環境的影響。推動該市場發展的關鍵因素包括對合成化學品日益嚴格的監管以及全球對有機食品生產不斷成長的需求。產業績效指標也印證了這個正面趨勢,顯示這些材料的應用範圍正在不斷擴大。例如,國際生物防治製造商協會 (IBMA) 報告稱,歐洲生物防治市場規模預計在 2024 年將達到 16 億歐元,這凸顯了經濟向永續農業實踐的重大轉變,而這種轉變正是生物防治軟體動物產業的基礎。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 3.879億美元 |
| 市場規模:2031年 | 5.1215億美元 |
| 複合年成長率:2026-2031年 | 4.74% |
| 成長最快的細分市場 | 金屬醛 |
| 最大的市場 | 亞太地區 |
然而,新生物成分冗長且高成本的監管核准流程對市場構成重大障礙。製造商經常面臨不同地區註冊制度的不一致,導致產品上市延遲和研發成本增加。這種監管瓶頸減緩了先進生物解決方案的普及,尤其是在控制入侵性軟體動物物種方面,阻礙了該行業有效滿足快速成長的農業需求。
對合成化學軟體動物控制劑的嚴格監管正成為全球格局轉變的重要催化劑。由於甲醛等傳統活性成分會在水源中殘留,且對非目標野生動物具有毒性,世界各地的監管機構正積極將其從市場上移除。這種法律壓力正推動著人們轉向磷酸鐵等生物替代品,這些替代品既能有效保護作物,又能遵守更嚴格的環境安全通訊協定。產業為因應這些法規而做出的策略調整已反映在主要農化公司的財務表現中。根據先正達集團於2024年4月發布的“2023年全年財務業績”,該公司生物農藥部門的銷售額成長了11%,表明其正迅速擺脫對傳統化學農藥的商業性。
同時,全球有機和永續農業的加速發展正成為市場需求的第二個關鍵促進因素。隨著生產者努力獲得禁止使用合成材料的認證,使用經有機認證的蝸牛和蛞蝓防治劑變得至關重要,而強調保護土壤生物多樣性的低風險綜合蟲害管理(IPM)策略進一步推動了這一趨勢。 FiBL(有機農業金融研究所)於2024年2月發布的《2024年世界有機農業》報告強調了這一市場的巨大潛力,報告指出,全球有機農地面積已超過9600萬公頃。因此,領先的開發商獲得了豐厚的回報。例如,Corteva AgriScience在其於2024年2月發布的《2023會計年度年度報告》中指出,其生物農藥產品組合的淨銷售額已達到約4.2億美元,凸顯了這一以永續性為導向的領域的巨大經濟價值。
冗長且高成本的監管核准流程是全球生物軟體動物市場擴張的一大障礙。生物活性成分通常需遵循最初為合成化學品製定的註冊框架,而這些框架往往並不適用於天然化合物。這種不匹配導致不同司法管轄區對數據的要求繁多,測試通訊協定也各不相同,迫使生產商將大量資源投入合規而非創新。因此,新型生物軟體動物產品上市所需時間大幅延長,導致獲利延遲,並阻礙了缺乏足夠財力應對複雜繁瑣核准流程的中小型生物技術公司進行投資。
這種監管效率低下直接限制了農業生產者獲得永續害蟲防治方案的機會。當產品核可停滯不前時,該行業無法迅速應對新出現的入侵性軟體動物威脅,迫使農民依賴過時的化學處理方法。近期行業統計數據表明,這種營運限制的嚴重性不容忽視。根據國際生物醫學製造商協會(IBMA)的數據,到2024年,歐盟生物醫學解決方案的監管審查期限已延長至最長10年。這一期限與其他農業市場快速得多的審查週期形成鮮明對比,嚴重阻礙了該行業的擴張和有效競爭力。
隨著製造商努力克服傳統生物防治方法的有效性局限性,對微生物和線蟲解決方案的研發投入不斷增加,產品平臺正在發生根本性的變化。領先的農藥公司正積極將研發重點轉向發酵技術和寄生線蟲(例如雌雄同體線蟲),開發出殺螺劑,其殺螺效果可與合成化學品媲美,同時又能規避嚴格的殘留物法規。這種創新驅動力得益於以永續投入為核心的產品系列的商業性成功。根據UPL有限公司於2024年5月發布的“2024年第四季度及全年業績更新”,其差異化和永續產品組合(包括天然植物保護解決方案)的銷售額已成長至其作物保護業務總額的約35%,這表明市場正顯著轉向這些先進的生物技術。
同時,生物防治劑在可控環境農業(CEA)和溫室中的應用日益廣泛,正成為該產業的高價值成長領域。在高濕度環境下種植作物,而這種環境會促進蛞蝓和蝸牛的繁殖,種植者越來越依賴生物藥品來滿足高階零售供應鏈的零殘留需求。這種需求正在推動大規模資本投資,旨在擴大用於覆蓋作物的特殊生物防治劑的生產。例如,在2024年1月發布的題為「M&G Investments向Biobest投資7,500萬歐元」的新聞稿中,Biobest集團宣布已獲得7,500萬歐元的股權投資,用於支持其在全球生物農藥市場的持續業務擴張,凸顯了支撐這一細分農業領域的強勁資金勢頭。
The Global Biological Molluscicides Market is projected to expand from USD 387.90 Million in 2025 to USD 512.15 Million by 2031, reflecting a compound annual growth rate of 4.74%. These pest control agents, formulated from natural sources such as bacteria and plant extracts, are designed to suppress snail and slug populations with negligible environmental impact. The primary forces driving this market include increasingly stringent prohibitions on synthetic chemicals and a growing global appetite for organic food production. This positive momentum is corroborated by sector performance metrics indicating wider acceptance of these inputs; for instance, the International Biocontrol Manufacturers Association reported in 2024 that the European biocontrol market reached a valuation of 1.6 billion Euros, highlighting a significant economic shift toward sustainable agricultural methods that supports the biological molluscicide industry.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 387.90 Million |
| Market Size 2031 | USD 512.15 Million |
| CAGR 2026-2031 | 4.74% |
| Fastest Growing Segment | Metaldehyde |
| Largest Market | Asia Pacific |
However, the market faces a substantial hurdle in the form of lengthy and costly regulatory approval procedures for new biological ingredients. Manufacturers frequently encounter disjointed registration systems across various regions, which delays product launches and inflates development expenses. This regulatory bottleneck notably retards the deployment of advanced biological solutions required to manage invasive mollusk species, thereby preventing the industry from effectively satisfying the escalating agricultural demand.
Market Driver
Rigorous regulatory constraints regarding synthetic chemical molluscicides act as the principal catalyst reshaping the global landscape. Authorities worldwide are actively removing conventional active ingredients, such as metaldehyde, from the market due to their persistence in water sources and toxicity to non-target wildlife. This legislative pressure compels a shift toward biological substitutes like ferric phosphate, which adhere to tighter environmental safety protocols while ensuring effective crop protection. The industry's strategic pivot in response to these regulations is reflected in the financial results of major agrochemical entities; according to Syngenta Group's 'Full Year 2023 Financial Results' released in April 2024, sales within their Biologicals segment increased by 11 percent, demonstrating a rapid commercial transition away from traditional chemistries.
Simultaneously, the accelerated growth of global organic farming and sustainable agriculture functions as a second vital driver of market demand. As producers strive to attain certifications that ban synthetic inputs, the use of organically approved snail and slug control formulations becomes mandatory, a trend further supported by Integrated Pest Management (IPM) strategies favoring low-risk options to protect soil biodiversity. The scale of this market potential is highlighted by the Research Institute of Organic Agriculture (FiBL) in its February 2024 'World of Organic Agriculture 2024' report, which notes that global organic agricultural land has surpassed 96 million hectares. Consequently, leading developers are seeing substantial revenue; for example, Corteva Agriscience reported in its February 2024 '2023 Annual Report' that its biologicals portfolio achieved net sales of roughly 420 million U.S. Dollars, underscoring the strong economic value of this sustainability-oriented sector.
Market Challenge
The protracted and expensive regulatory approval process constitutes a significant barrier to the expansion of the Global Biological Molluscicides Market. Biological active ingredients are frequently subjected to registration frameworks originally established for synthetic chemicals, which are often inappropriate for natural compounds. This lack of alignment leads to exhaustive data demands and disparate testing protocols across various jurisdictions, compelling manufacturers to direct significant resources toward compliance rather than innovation. As a result, the time needed to introduce new biological molluscicides to the market is dramatically extended, postponing revenue streams and discouraging investment from smaller biotechnology firms that lack the financial resilience to manage such complex bureaucratic requirements.
This regulatory inefficiency directly limits the accessibility of sustainable pest control solutions for agricultural producers. When product approvals are stalled, the industry is unable to react quickly to new invasive mollusk threats, forcing farmers to depend on outdated chemical treatments. The gravity of this operational constraint is illustrated by recent industry statistics; according to the International Biocontrol Manufacturers Association in 2024, the regulatory review timeline for biocontrol solutions in the European Union has stretched to as long as ten years. This duration is in sharp contrast to the more expedited timelines seen in other agricultural markets, significantly hindering the sector's capacity to expand and compete effectively.
Market Trends
Increasing research and development spending on microbial and nematode-based solutions is fundamentally transforming product pipelines as manufacturers aim to address the efficacy limitations of earlier biological generations. Leading agrochemical firms are aggressively shifting focus toward fermentation technologies and parasitic nematodes, such as Phasmarhabditis hermaphrodita, to create molluscicides that achieve mortality rates similar to synthetic chemicals while avoiding strict residue restrictions. This push for innovation is substantiated by the commercial performance of portfolios focused on these sustainable inputs; according to UPL Ltd's 'Q4 & Full Year FY24 Results Update' from May 2024, the share of the company's differentiated and sustainable portfolio, which includes natural plant protection solutions, increased to roughly 35 percent of its total crop protection revenue, indicating a strong market transition toward these advanced biological technologies.
Concurrently, the rising use of biological molluscicides in Controlled Environment Agriculture (CEA) and greenhouses represents a high-value growth avenue for the industry. Growers in these high-humidity settings, which are conducive to slug and snail proliferation, are increasingly turning to biological agents to meet the zero-residue requirements of premium retail supply chains. This demand is driving significant capital investment intended to expand the production of specialized biological controls for covered crops. For instance, Biobest Group announced in a January 2024 press release titled 'M&G Investments Invests EUR 75 Million In Biobest' that it had secured an equity investment of 75 million Euros to fund its ongoing expansion in the global biological crop protection market, highlighting the substantial financial momentum supporting this niche agricultural sector.
Report Scope
In this report, the Global Biological Molluscicides Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Biological Molluscicides Market.
Global Biological Molluscicides Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: